2022 - Research.com Medicine in Poland Leader Award
Jan Lubinski spends much of his time researching Breast cancer, Internal medicine, Oncology, Genome-wide association study and Genetics. Breast cancer is a subfield of Cancer that Jan Lubinski studies. His Cancer research focuses on subjects like Endocrinology, which are linked to Gene mutation.
Jan Lubinski has researched Oncology in several fields, including Germline mutation, BRCA mutation, Ovarian cancer, Chemotherapy and Relative risk. His Genome-wide association study research is multidisciplinary, incorporating elements of Case-control study, Genetic association, Locus and Bioinformatics. His Allele study integrates concerns from other disciplines, such as Molecular biology and Disease.
The scientist’s investigation covers issues in Internal medicine, Breast cancer, Oncology, Cancer and Genetics. His work deals with themes such as Germline mutation and Genotype, which intersect with Internal medicine. His Breast cancer research is multidisciplinary, incorporating perspectives in CHEK2, Cancer research, Gynecology and Case-control study.
His Oncology study incorporates themes from Genetic predisposition, Hazard ratio, Prostate cancer, Family history and Risk factor. His biological study spans a wide range of topics, including Gastroenterology, Lung cancer, Pathology and Immunology. His study in Genome-wide association study is interdisciplinary in nature, drawing from both Genetic association and Bioinformatics.
Jan Lubinski mostly deals with Internal medicine, Oncology, Breast cancer, Cancer and Odds ratio. Jan Lubinski focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Lung cancer. His work deals with themes such as Germline mutation, PALB2, Ovarian cancer, Allele and Prostate cancer, which intersect with Oncology.
His Breast cancer research incorporates themes from Genome-wide association study, Family history and Mutation. The various areas that Jan Lubinski examines in his Genome-wide association study study include Genetic association and Medical genetics. His Cancer research integrates issues from Gene and Germline.
Internal medicine, Breast cancer, Oncology, Cancer and Genome-wide association study are his primary areas of study. His research investigates the connection with Breast cancer and areas like Genetic testing which intersect with concerns in CHEK2, PALB2, Mutation and Genotyping. His Oncology research includes elements of Serous fluid, Ovarian tumor, Ovarian cancer and Prostate cancer.
His Ovarian cancer study combines topics in areas such as Oophorectomy, Tobacco smoke and Population study. His Genome-wide association study research incorporates elements of Disease, Genetic association, Bioinformatics and Medical genetics. Jan Lubinski has included themes like Genetic model and Expression quantitative trait loci in his Genetic association study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou;Pdp Pharoah;S Narod;HA Risch.
American Journal of Human Genetics (2003)
HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review
Henry T Lynch;Jane F Lynch;Trudy G Shaw;Jan Lubiński.
Hereditary Cancer in Clinical Practice (2003)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong;Timothy A. Yap;David S. Boss;Craig P. Carden.
Journal of Clinical Oncology (2010)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: